Top Markets
#1 Islamic Coin Islamic Coin +155.98%
#2 Siren Siren +37.35%
#3 Venom Venom +21.93%
#4 Arowana Arowana +21.86%
#5 RedStone RedStone +15.45%
#6 Verus Coin Verus Coin +15.11%
#7 Perle Perle +13.58%
#8 KUB Coin KUB Coin +12.98%
#9 OpenEden OpenEden +11.97%
#10 Janction Janction +10.89%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
A-SPINE Asia Co., Ltd. A-SPINE Asia Co., Ltd.

A-SPINE Asia Co., Ltd.

6758
Rank in Stocks #31662
A-SPINE Asia Co., Ltd. functions as a medical device enterprise, specializing... A-SPINE Asia Co., Ltd. functions as a medical device enterprise, specializing in the entire cycle of research, development, production, and worldwide distribution of spinal implants and surgical instruments. The company's market presence spans numerous countries, including Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. Their product catalog features a variety of spinal stabilization systems, such as solutions for cervical anterior fixation, alongside thoracic and lumbar fixation devices. Additionally, A-SPINE Asia provides a comprehensive range of interbody fusion systems, encompassing ACDF, PLIF, TLIF, and ALIF cages. Its offerings further extend to balloon kyphoplasty and vertebral body replacement devices. Beyond its own manufactured products, the firm also acts as a distributor for a selection of imported orthopedic medical equipment. Established in 2001, A-SPINE Asia Co., Ltd. is based in New Taipei City, Taiwan.
Share Price
$0.92535171
Last synced: 2026-08-17
Market Cap
$12.47M
Change (1 day)
0.00%
Change (1 year)
-33.83%
Country
TW
Trade A-SPINE Asia Co., Ltd. (6758)

Category

Healthcare
P/E ratio for A-SPINE Asia Co., Ltd. (6758)
P/E ratio as of 2026 TTM: 0
According to A-SPINE Asia Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for A-SPINE Asia Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.